Cargando…
Design, synthesis, and biological evaluation of histone deacetylase inhibitor with novel salicylamide zinc binding group
INTRODUCTION: Histone deacetylases (HDACs) have emerged as important therapeutic targets for various diseases, such as cancer and neurological disorders. Although a majority of HDAC inhibitors use hydroxamic acids as zinc binding groups, hydroxamic acid zinc-binding groups suffer from poor bioavaila...
Autores principales: | Kim, Ji Hyun, Ali, Khan Hashim, Oh, Yong Jin, Seo, Young Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276175/ https://www.ncbi.nlm.nih.gov/pubmed/35512065 http://dx.doi.org/10.1097/MD.0000000000029049 |
Ejemplares similares
-
Zinc binding groups for histone deacetylase inhibitors
por: Zhang, Lei, et al.
Publicado: (2018) -
Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases
por: Frühauf, Anton, et al.
Publicado: (2021) -
Histone deacetylase HDAC1 expression correlates with the progression and prognosis of lung cancer: A meta-analysis
por: Cao, Lin-Lin, et al.
Publicado: (2017) -
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group
por: Linciano, Pasquale, et al.
Publicado: (2021) -
Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors
por: Spencer, John, et al.
Publicado: (2011)